unknown by Lasley, Robert D.
2 8 2 Letters to the Editor 
The Journal of Thoracic and 
Cardiovascular Surgery 
July 1995 
consin solution when used for cardioplegia at moderate 
hypothermia: comparison with the St. Thomas' Hospi- 
tal solution at 4 ~ C. Circulation 1992;86(Suppl 5): 
II280-8. 
4. Selke FW, Shafique T, Schoen FJ, Weintraub RM. 
Impaired endothelium dependent coronary microvas- 
cular relaxation after cold potassium cardioplegia nd 
reperfusion. J THORAC CARDIOVASC SURG 1993;105: 
52-8. 
5. Worthington M, von Oppell U, Sutherland J, Human 
P, Schwalb H, Borman J. Comparison of myocardial 
preservation solutions in an 18-hour porcine paracor- 
poreal model [Abstract]. Cardiovasc J of South Africa 
1994;5(Suppl):27. 
12/8/61690 
Reply to the Editor: 
We thank Drs. Boehm and Reichart for their interest in 
our recent study on the role of adenosine in University of 
Wisconsin (UW) preservation solution. 1 In these studies 
we reported that omission of adenosine from UW solution 
markedly reduced the functional recovery of isolated 
perfused rabbit hearts after 18 hours of hypothermic 
(4 ~ C) preservation. Functional recovery in hearts pre- 
served with UW solution without adenosine was similar to 
that in hearts preserved with St. Thomas' Hospital solu- 
tion. We concluded that adenosine plays a key role in the 
enhanced myocardial preservation observed with UW 
solution. 
We agree with Drs. Boehm and Reichart that the 
question remains as to whether inclusion of adenosine in 
St. Thomas' Hospital solution would have produced the 
same functional recovery as in UW solution. Addition of 
adenosine to St. Thomas' Hospital solution would have 
likely produced the same interstitial fluid profile as seen 
with UW solution and improved the preservation, but, 
because the two solutions are so different in composition, 
it is difficult to say whether the functional recovery would 
have been equivalent to that of UW solution. However, 
the purpose of this study was to determine whether 
adenosine was a necessary component of UW solution, 
not to compare the preservation capabilities of the two 
different solutions. The St. Thomas' Hospital solution 
group was included in this study merely for comparison 
purposes. 
The composition of UW solution is based on the 
complications associated with prolonged hypothermia and 
ischemia, but few studies have assessed which of these 
components play an integral role in preservation. 2 The 
results of this study indicate that adenosine is a key 
component of UW solution. In addition, Ko and col- 
leagues 3 recently reported that reversal of the sodium- 
potassium composition or omission of hydroxyethyl starch 
resulted in less preservation of diastolic function after 6 
hours preservation (1~ to 2 ~ C) of canine hearts. We agree 
that the effects of the high potassium concentration (in 
UW solution) on vascular/endothelial function must be 
studied further; however, in this study no evidence was 
found of more vascular dysfunction in hearts preserved 
with UW solution than in those preserved with St. Tho- 
mas' Hospital solution. Furthermore, in the study by 
Amrani and colleagues 4 cited by the respondents, the 
cold-storage temperature was much higher (20 ~ C) than 
that for which the UW solution was designed (4 ~ C). 
In conclusion, on the basis of experimental results, it 
appears that UW solution may be superior to St. Thomas' 
Hospital solution for prolonged myocardial preservation 
because of the inclusion of adenosine and hydroxyethyl 
starch and its intracellular-based ionic composition. How- 
ever, because clinical preservation times have remained in 
the 4 to 5 hour range for the past decade, it is evident hat 
much Work remains to be done in the area of myocardial 
preservation for heart transplantation. 
Robert D. Lasley, PhD 
Department of Surgery 
University of Wisconsin at Madison 
Madison, WI 53792 
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Invited letter concerning: Biochemical and cellular 
characterization of cardiac valve tissue after 
cryopreservation or antibiotic preservation 
(J THORAC CAROIOVASC SUING 1994;108:63-7) 
To the Editor." 
The vexing question of whether aortic valve allografts 
survive longer when their donor cell population isviable at 
implantation has been debated now for more than 20 
years. Truly conclusive vidence in favor Of maintaining 
cell viability during the preparation and storage of grafts is 
still lacking. Most follow-up studies of so-called "viable" 
valve grafts have not attempted to establish the persis- 
tence of donor cells in the explanted valves or to define 
the histologic status of the grafts. A notable exception is 
the paper of O'Brien and colleagues, 1 who demonstrated 
persistent donor cells in one single case of the series they 
studied. Despite good cellularity, however, this graft did 
not exhibit normal eaflet architecture. Without adequate 
cytologic and histologic information on the "viable" graft 
at the end of its useful life, the possibility remains 2 that 
